drugset / Trial / NCT02895958
The Dublin Zepatier Study
Phase 4
Terminated
3 enrolled
Mater Misericordiae University Hospital
Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of Zepatier in a community-based setting among cirrhotic and non-cirrhotic patients on stable opiate substitution therapy.
Timeline
- Start
- 2018-03-15
- Primary completion
- 2019-05-23
- Completion
- 2019-12-06
Outcome
Outcome not reported
Stopped (Enrollment): “Insufficient study participants enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elbasvir | Small molecule | — | — |
| Subject | GRAZOPREVIR ANHYDROUS | Small molecule | — | — |
| Subject | Ribavirin | Small molecule | — | — |